News

Novartis: Q2 Earnings Review - Solid Results Justify All-Time High Share Price
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
Kinder Morgan Reports Better-Than-Expected Q2 Results: Details
The Details: Kinder Morgan reported quarterly earnings of 28 cents per share, which beat the analyst consensus estimate of 27 ...
Novartis13h
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...
CVS Health - Q2 Earnings Are A Referendum On The Future Of Company
For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...
InvestorsHub on MSN6h
Abbott’s Q2 revenue surpasses expectations despite share decline
The healthcare leader posted adjusted earnings per share of $1.26 for the quarter, slightly above the consensus estimate of ...
StockStory.org on MSN7h
Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q2 CY2025, with sales up 7.4% year on year to $11.14 ...
IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine.
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...